43
Views
3
CrossRef citations to date
0
Altmetric
Original

Effective drug policy: a new approach demonstrated in the Drug Policy Modelling Program

, , , , , , , , , , , , , , , , , , & show all
Pages 265-271 | Received 15 Jun 2006, Accepted 18 Dec 2006, Published online: 12 Jul 2009

References

  • Collins D J, Lapsley H M. Counting the cost: estimates of the social costs of drug abuse in 1998 – 1999. Commonwealth of Australia, Canberra 2002
  • Anderson L M, Brownson R C, Fullilove M T, Teutsch S M, Novick L F, Fielding J, et al. Evidence-based public health policy and practice: promises and limits. Am J Prevent Med 2005; 28(5 Suppl. 1)226–230
  • Weiss C H, Murphy-Graham E, Birkeland S. An alternate route to policy influence: how evaluations affect D.A.R.E. Am J Eval 2005; 26: 12–30
  • V Lin, Gibson, B. Evidence-based health policy. Problems and possibilities. Oxford, Oxford University Press. 2003
  • Ritter A, McDonald D. Monograph No. 02: Drug policy interventions: a comprehensive list and a review of classification schemes. DPMP Monograph Series, Turning Point Alcohol and Drug Centre, Fitzroy 2005
  • Winkler D, Caulkins J P, Behrens D A, Tragler G. Estimating the relative efficiency of various forms of prevention at different stages of a drug epidemic. Socio-Econ Plan Sci 2004; 38: 43–56
  • Everingham S S, Rydell C P. Modeling the demand for cocaine. RAND Corporation, Santa Monica 1994
  • Lindblom C E. The science of ‘muddling through’. Public Admin Rev 1959; 19: 79–88
  • Gregrich R J. A note to researchers: communicating science to policy makers and practitioners. J Subst Abuse Treat 2003; 25: 233–237
  • Secker A. The policy-research interface: an insider's view. Addiction 1993; 88(Suppl.)115S–120S
  • Bammer G. Integration and implementation sciences: building a new specialization. Ecol Society 2005; 10(2)6, (online URL: http://www.ecologyandsociety.org/vol10/iss2/art6/)
  • Bammer G. A new science for integration and implementation. Complex science for a complex world – exploring human ecosystems with agents, P Perez, D Batten. ANU Press, Canberra 2006; 95–107
  • Bammer G, Deane P. Bulletin No. 17: Integration in DPMP: an organising principle and an expanded set of tools. DPMP Bulletin Series, Turning Point Alcohol and Drug Centre, Fitzroy 2005
  • Mazerolle L, Soole D, Rombouts S. Drug law enforcement: A review of the evaluation literature. Police Quart, in press
  • Ritter A, Cameron J. Monograph No. 06: A systematic review of harm reduction. DPMP Monograph Series, Turning Point Alcohol and Drug Centre, Fitzroy 2005
  • Soole D W, Mazerolle L, Rombouts S. Monograph No. 07: School based drug prevention: a systematic review of the effectiveness on illicit drug use. DPMP Monograph Series, Turning Point Alcohol and Drug Centre, Fitzroy 2005
  • Mazerolle L, Soole D, Rombouts S. Street-level drug law enforcement: a meta-analytic review. J Exp Criminol 2006; 2: 409–435
  • Choi B CK, Pang T, Lin V, Puska P, Sherman G, Goddard M, et al. Can scientists and policy makers work together?. J Epidemiol Comm Health 2005; 59: 632–637
  • Crosswaite C, Curtice L. Disseminating research results – the challenge of bridging the gap between health research and heath action. Health Promot Int 1994; 9: 289–296
  • Gibson B. Beyond ‘two communities’. Evidence-based health policy. Problems and possibilities, V Lin, B Gibson. Oxford University Press, Oxford 2003
  • Lin V. Competing rationalities: evidence-based health policy?. Evidence-based health policy. Problems and possibilities, V Lin, B Gibson. Oxford University Press, Oxford 2003; 3–17
  • Colebatch H K. Policy 2nd ed. Open University Press, Philadelphia 2002
  • McDonald D, Bammer G, Breen G. Monograph No. 04: Australian illicit drugs policy: mapping structures and processes. DPMP Monograph Series, Turning Point Alcohol and Drug Centre, Fitzroy 2005
  • Lewis J M. Being around and knowing the players: networks of influence in health policy. Soc Sci Med 2006; 62: 2125–2136
  • Midgley G. Systemic intervention: philosophy, methodology and practice. Plenum/Kluwer, New York 2000
  • Midgley G, Winstanley A, Gregory W, Foote J. Monograph No. 13: Scoping the potential uses of systems thinking in developing policy on illicit drugs. DPMP Monograph Series, Turning Point Alcohol and Drug Centre, Fitzroy 2005
  • Midgley G, Winstanley A, Gregory W, Foote J. Bulletin No. 11: Scoping the potential uses of systems thinking in developing policy on illicit drugs. DPMP Bulletin Series, Turning Point Alcohol and Drug Centre, Fitzroy 2005
  • Hough L. A meeting of the minds. Spring, 2002; 32–37, What happens when the Kennedy School's executive sessions unite practitioners and academics together? Harvard University John F Kennedy School of Government Bulletin (http://www.ksg. harvard.edu/ksgpress/bulletin/spring2002/features/meeting. html)
  • Moore M H, Hartmann F X. On the theory and practice of ‘Executive Sessions’. 1999, Unpublished
  • Bammer G. Bulletin No. 4: Exploring executive sessions to generate effective new approaches to illicit drugs. DPMP Bulletin Series, Turning Point Alcohol and Drug Centre, Fitzroy 2005
  • Vos T, Haby M, Magnus A, Mihalopoulos C, Andrews G, Carter R. Assessing the cost-effectiveness in mental health: helping policy-makers prioritize and plan health services. Aus NZ J Psychiatry 2005; 39: 701–712
  • Moore T, Ritter A, Caulkins J. Bulletin No. 12: Economic modelling: cost-effectiveness of three policy options. DPMP Bulletin Series, Turning Point Alcohol and Drug Centre, Fitzroy 2005
  • Ross J, Teesson M, Darke S, Lynskey M, Ali R, Ritter A, et al. Twelve month outcomes of treatment for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). National Drug and Alcohol Research Centre, University of New South Wales, Sydney, New South Wales 2003
  • Caulkins J, Dietze P, Ritter A. Dynamic compartmental model of trends in Australia drug use. Health Care Manag Sci (in press)
  • Moore T J. Monograph No. 01: What is Australia's ‘drug budget’? The policy mix of illicit drug-related government spending in Australia. DPMP Monograph Series, Turning Point Alcohol and Drug Centre, Fitzroy 2005
  • Moore T J, Caulkins J P, Ritter A, Dietze P, Monagle S, Pruden J. Monograph No. 09: Heroin markets in Australia: current understandings and future possibilities. DPMP Monograph Series, Turning Point Alcohol and Drug Centre, Fitzroy 2005
  • Caulkins J, Reuter P. What price data tells us about drug markets. J Drug Iss 1998; 28: 593–613
  • Godkin C, Caulkins J, Dietze P. Bulletin No. 9: Examination of heroin and amphetamine purity in Victoria. DPMP Bulletin Series, Turning Point Alcohol and Drug Centre, Fitzroy 2005
  • Moore T, Caulkins J, Dietze P. Bulletin No. 8: Illicit drugs in Australia: what do we know about the role of price?. DPMP Bulletin Series, Turning Point Alcohol and Drug Centre, Fitzroy 2005
  • Moore T. Bulletin No. 10: The impact of heroin seizures (economic back of the envelope calculations). DPMP Bulletin Series, Turning Point Alcohol and Drug Centre, Fitzroy 2005
  • Rescher N. Complexity: a philosophical overview. Transaction Publishers, New Brunswick, New Jersey 1998
  • Holland J H. Hidden order: how adaptation builds complexity. Addison-Wesley, Reading, Mass. 1995
  • Perez P, Dray A, Ritter A, Dietze P, Moore T, Mazerolle L. SimDrug: exploring the complexity of illicit drug markets. Complex science for a complex world – exploring human ecosystems with agents, P Perez, D Batten. ANU Press, Canberra 2006; 193–224
  • Perez P, Dray A. Monograph No. 11: SimDrug: exploring the complexity of heroin use in Melbourne. DPMP Monograph Series, Turning Point Alcohol and Drug Centre, Fitzroy 2005
  • Agar M. Agents in living color: towards emic agent-based models. J Artific Soc Soc Sim 2005; 8(1), http://jasss.soc.surrey.ac.uk/8/1/4.html
  • Agar M, Wilson D. DrugMart: heroin epidemics as complex adaptive systems. Complexity 2002; 7: 44–52
  • Caulkins J P, Behrens D A, Knoll C, Tragler G, Zuba D. Modeling dynamic trajectories of initiation and demand: the case of the US cocaine epidemic. Health Care Manage Sci 2004; 7: 319–329
  • Levy D T, Chaloupka F, Gitchell J, Mendez D, Warner K E. The use of simulation models for the surveillance, justification, and understanding of tobacco control policies. Health Care Manage Sci 2002; 5: 113–120
  • Rossi C. A mover-stayer type model for epidemics of problematic drug use. Bull Narcot 2001; 53: 39–64
  • Tengs T O, Ahmad S, Moore R, Gage E. Federal policy mandating safer cigarettes: a hypothetical simulation of the anticipated population health gains or losses. J Pol Anal Manage 2004; 23: 857–872
  • Godfrey C, Stewart D, Gossop M. Economic analysis of costs and consequences of the treatment of drug misuse: 2-year outcome data from the National Treatment Outcome Research Study (NTORS). Addiction 2004; 99: 697–707
  • Smithson M. Ignorance and uncertainty: emerging paradigms. Springer-Verlag, New York 1989
  • Gorman D M, Gruenewald P J, Hanlon P J, Mezic I, Waller L A, Castillo-Chavez C, et al. Implications of systems dynamic models and control theory for environmental approaches to the prevention of alcohol and other drug use-related problems. Subst Use Misuse 2004; 39: 1713–1750
  • Giacomini M. Interdisciplinarity in health services research: dreams and nightmares, maladies and remedies. J Health Serv Res Pol 2004; 9: 177–184

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.